Pharmaceuticals News and Research

RSS

Savient Pharmaceuticals to initiate public offering of 4,000,000 shares

Savient Pharmaceuticals, Inc. announced its intention to commence, subject to market and other conditions, an underwritten public offering of 4,000,000 shares of its common stock pursuant to an effective shelf registration statement on Form S-3.

8 Oct 2009

Mimetogen Pharmaceuticals completes its equity financing

Mimetogen Pharmaceuticals Inc. ("Mimetogen"), a privately held drug development company announced today that it has successfully completed an equity financing, co-led by Boston-based VIMAC Milestone Medica Fund and Montréal-based iNovia Capital.

8 Oct 2009

Lions Eye Institute for Transplant & Research to study vision impairment and blindness

Real-time biomedical studies of factors leading to vision impairment are now possible through the world's largest ocular research center at Lions Eye Institute for Transplant & Research.

8 Oct 2009

Sinobiopharma receives certificate for using Gabexate Mesylate as pharmaceutical raw material

Sinobiopharma, Inc. ("Sinobiopharma") (the "Company") is pleased to announce that the Company received a certificate for the use of Gabexate mesylate as a pharmaceutical raw material (Certificate #2009S01805) from the Chinese State Food and Drug Administration ("SFDA").

8 Oct 2009

Labopharm's trazodone API supplier Angelini resolves manufacturing facility deficiencies

Labopharm Inc. today announced that it has been informed by Angelini, the manufacturer of the active pharmaceutical ingredient (API) for the Company's novel trazodone formulation, that it has received a letter from the U.S. Food and Drug Administration (FDA) stating that Angelini has appropriately addressed all deficiencies cited by the FDA following its inspection of the manufacturing facility in June and July of this year.

8 Oct 2009

AMAG Pharmaceuticals to present three abstracts at ASN Renal Week meeting

AMAG Pharmaceuticals, Inc. today announced that three abstracts have been accepted for presentation at the American Society of Nephrology (ASN) Renal Week meeting being held October 27-November 1, 2009 in San Diego, CA.

8 Oct 2009

Obesity and diabetes-2 increase the risk of serious health problems and reduce quality of life

Over the last 10-20 years, the number of cases of obesity and diabetes-2 has risen dramatically. The WHO considers obesity-related illnesses to be one of the world's biggest health problems. Obesity and diabetes-2 do not just reduce the quality of life but also dramatically increase the risk of serious health problems, such as cardiovascular diseases.

8 Oct 2009

HTDS' Hepatitis A vaccine receives GMP Certificate from the Russian FDA

HTDS www.htdsmedical.com (HTDS) - The issuer's China based operating subsidiary Mellow Hope www.mellowhope.com is pleased to announce that its Hepatitis A Live Attenuated Vaccine (Brand name: Mevac-A) associate operation plant has obtained the GMP Certificate (Good Manufacturing Practice See Description http://en.wikipedia.org/wiki/Good_manufacturing_practice) from the Russian FDA. http://www.who.int/hiv/HIVCP_RUS.pdf

8 Oct 2009

New mechanism of bone formation may help fight osteoporosis

The natural cycle of building bone to maintain skeletal strength and then breaking it down for the body's calcium needs is delicately balanced, but diseases like osteoporosis break down too much bone without adequate bone replacement, leading to bone fractures.

8 Oct 2009

Global pharmaceutical market to grow by 4 - 6 percent: IMS Health

IMS Health reported today that the value of the global pharmaceutical market in 2010 is expected to grow 4 - 6 percent on a constant-dollar basis, exceeding $825 billion, driven by stronger near-term growth in the U.S. market.

8 Oct 2009

Napo Pharmaceuticals hosts educational panel to address global health and environment

Napo Pharmaceuticals, Inc. (Napo) recently hosted an educational panel to address the impact of the lack of access to clean water and enteric disease on global health, the environment, and human rights.

8 Oct 2009

APP Pharmaceuticals receives FDA approval to market Sumatriptan Succinate Injection

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: APCVZ) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Sumatriptan Succinate Injection, USP, in two dosage strengths.

8 Oct 2009

Effective use of economic incentives and clinical tools help employers to control drug benefit costs

Employers are effectively controlling drug benefit costs and utilization, according to research findings in the Pharmacy Benefit Management Institute's (PBMI) 2009-2010 Prescription Drug Benefit Cost and Plan Design Report. PBMI's employer survey shows the average rate of increase in drug costs has dropped to 4.4%, the lowest rate of increase since PBMI began conducting the study in 1995.

8 Oct 2009

Epizyme raises $32 million through its Series B financing

Epizyme, Inc., a biopharmaceutical company translating key discoveries in the field of epigenetics into novel pharmaceutical agents, announced today the closing of a $32 million Series B financing led by new investor Bay City Capital (BCC).

8 Oct 2009

Zenvia patent application: AVANIR Pharmaceuticals receives USPTO "Notice of Allowance"

AVANIR Pharmaceuticals, Inc. today announced that it has received a “Notice of Allowance” from the United States Patent and Trademark Office (USPTO) announcing that it intends to grant the Company a new patent, extending the period of commercial exclusivity for its lead drug candidate Zenvia™ well into 2025.

8 Oct 2009

Dutch provide lessons on health reform, while Europe's highest court rules for drug maker

In a series about the health care systems in five countries, the NewsHour examines the Netherlands and its massive health care overhaul. "When the Netherlands redesigned its national health care system in 2006, there were three main goals: continue universal coverage, unleash competition between private insurers, and keep down costs for the long run.

8 Oct 2009

Callidus Software signs SaaS deal to provide market-leading SPM services

Callidus Software Inc., the leader in Sales Performance Management (SPM), today announced it signed a major new customer for its on-demand Monaco suite. The agreement was signed in the third quarter of 2009.

8 Oct 2009

Amarillo Biosciences, Intas Pharmaceuticals enter strategic partnership to combat influenza in India

Amarillo Biosciences, Inc. today announced that it has agreed to a strategic partnership with Intas Pharmaceuticals Limited (Intas), one of the top 20 pharmaceutical companies in India, whereby Intas will sponsor clinical trials of ABI's orally administered interferon-alpha lozenges in order to combat influenza. Intas will pay ABI a royalty on net sales after marketing approval is obtained in India.

8 Oct 2009

3M Drug Delivery Systems expands operations, establishes new facility at Singapore

3M Drug Delivery Systems today announced the expansion of its capabilities with a new laboratory site at the 3M Singapore facility in Yishun. The Singapore lab will develop products in both the inhalation and transdermal drug delivery categories, bringing 3M’s innovative inhalers and patches to pharmaceutical customers and patients in the Asia Pacific region.

8 Oct 2009

Peregrine Pharmaceuticals establishes a new Anti-Viral Research Group

Peregrine Pharmaceuticals, Inc. today announced that it has established a new Anti-Viral Research Group in its R&D organization.

7 Oct 2009

Pharmaceuticals News and Research

Savient Pharmaceuticals to initiate public offering of 4,000,000 shares

Mimetogen Pharmaceuticals completes its equity financing

Lions Eye Institute for Transplant & Research to study vision impairment and blindness

Sinobiopharma receives certificate for using Gabexate Mesylate as pharmaceutical raw material

Labopharm's trazodone API supplier Angelini resolves manufacturing facility deficiencies

AMAG Pharmaceuticals to present three abstracts at ASN Renal Week meeting

Obesity and diabetes-2 increase the risk of serious health problems and reduce quality of life

HTDS' Hepatitis A vaccine receives GMP Certificate from the Russian FDA

New mechanism of bone formation may help fight osteoporosis

Global pharmaceutical market to grow by 4 - 6 percent: IMS Health

Napo Pharmaceuticals hosts educational panel to address global health and environment

APP Pharmaceuticals receives FDA approval to market Sumatriptan Succinate Injection

Effective use of economic incentives and clinical tools help employers to control drug benefit costs

Epizyme raises $32 million through its Series B financing

Zenvia patent application: AVANIR Pharmaceuticals receives USPTO "Notice of Allowance"

Dutch provide lessons on health reform, while Europe's highest court rules for drug maker

Callidus Software signs SaaS deal to provide market-leading SPM services

Amarillo Biosciences, Intas Pharmaceuticals enter strategic partnership to combat influenza in India

3M Drug Delivery Systems expands operations, establishes new facility at Singapore

Peregrine Pharmaceuticals establishes a new Anti-Viral Research Group

Industry Focus - Biopharma eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring